Adaptive Biotechnologies (ADPT) Net Margin (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Net Margin of 28.24% for Q1 2026, down 49.08% sequentially from 18.94% in Q4 2025, and up 2864.0% YoY from 0.95% in Q1 2025.
Adaptive Biotechnologies (ADPT) Net Margin (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of Net Margin data on file, last reported at 28.24% in Q1 2026.
- Quarterly Net Margin rose 2864.0% year-over-year to 28.24% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.8% (up 5806.0% YoY) and the FY2025 annual result came in at 21.47%, up 6771.0% from the prior year.
- Net Margin eased to 28.24% in Q1 2026 per ADPT's latest filing, from 18.94% in the prior quarter.
- The five-year high for Net Margin was 10.16% in Q3 2025, with the low at 620.92% in Q2 2023.
- Average Net Margin over 5 years is 118.01%, with a median of 94.75% recorded in 2022.
- Year-over-year, Net Margin plunged 50163 bps in 2023 and jumped 51384 bps in 2024.
- Adaptive Biotechnologies' Net Margin stood at 72.77% in 2022, then slumped by 108 bps to 151.73% in 2023, then soared by 53 bps to 71.04% in 2024, then jumped by 73 bps to 18.94% in 2025, then tumbled by 49 bps to 28.24% in 2026.
- Business Quant data shows ADPT's Net Margin at 28.24% in Q1 2026, 18.94% in Q4 2025, and 10.16% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -5.68% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 15.06% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 17.29% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 24.41% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -12.22% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 18.47% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 3.40% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 12.28% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 17.89% |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | -28.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.24% |
| Dec 31, 2025 | -18.94% |
| Sep 30, 2025 | 10.16% |
| Jun 30, 2025 | -43.47% |
| Mar 31, 2025 | -56.88% |
| Dec 31, 2024 | -71.04% |
| Sep 30, 2024 | -69.12% |
| Jun 30, 2024 | -107.08% |
| Mar 31, 2024 | -113.52% |
| Dec 31, 2023 | -151.73% |
| Sep 30, 2023 | -132.72% |
| Jun 30, 2023 | -620.92% |
| Mar 31, 2023 | -153.27% |
| Dec 31, 2022 | -72.77% |
| Sep 30, 2022 | -94.75% |
| Jun 30, 2022 | -119.29% |
| Mar 31, 2022 | -162.60% |
| Dec 31, 2021 | -161.76% |
| Sep 30, 2021 | -141.89% |
| Jun 30, 2021 | -128.04% |